spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


 

For further information please contact:

Advertising
Chris Jones

Editorial  
Angela Cottrell

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 

pmps
 
 
Featured in this issue
Cool Chain, Cargo & Logistics
Temperature Control Regulations

Air Freight Innovation


When it comes to the transportation of pharmaceutical products, instead of localised regulations and procedures, the focus should be on implementing a global standard, argues Nathan De Valck of Brussels Airport Company.
Cool Chain, Cargo & Logistics
Supply Chain Efficiency

Made Simple


Brian Kohr of CSafe Global reveals that optimisation of the cold chain can give companies a critical advantage over their competitors and enable them to create simple, effective logistical processes.
  Cool Chain, Cargo & Logistics
Frozen Storage

The Chill Factor


Choosing the right printer media for frozen storage can be difficult. Rafael Hernández at Honeywell Scanning and Mobility thinks that partnering with the right provider and understanding the technical issues can lead to the solution.

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development
Published quarterly in
February, May,
August and November
Banner of Emballage.PMPS on Samedan
Banner of PCI on Samedan
 
Industry Events

Orphan Drugs and Rare Diseases

20-21 October 2014, Holiday Inn Regents Park Hotel, London, UK

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and theEarly Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.
More info >>

 
News and Press Releases

INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role

Raleigh, N.C., Oct. 1, 2014 - INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced Clare Grace, PhD, has joined the Company as Vice President, Site and Patient Access. In this new global leadership role, Dr. Grace will further develop and enhance the execution of INC Researchs vision to create stronger connections with high-performance clinical research sites and targeted patient populations. Dr. Grace brings nearly 20 years of strategic global clinical research leadership to the Company, including senior positions within the academic, pharmaceutical, biotech and CRO industries.
More info >>

air transport logo

 

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement